Authors:
Hess, DA
O'Leary, EF
Lee, JT
Almawi, WY
Madrenas, J
Rieder, MJ
Citation: Da. Hess et al., Inhibition of cytokine production and interference in IL-2 receptor-mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazole, FASEB J, 15(8), 2001, pp. NIL_136-NIL_161
Authors:
Shan, XC
Balakir, R
Criado, G
Wood, JS
Seminario, MC
Madrenas, J
Wange, RL
Citation: Xc. Shan et al., ZAP-70-independent Ca2+ mobilization and Erk activation in Jurkat T cells in response to T-Cell antigen receptor ligation, MOL CELL B, 21(21), 2001, pp. 7137-7149
Citation: La. Chau et al., Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3, TRANSPLAN P, 33(1-2), 2001, pp. 528-529
Citation: La. Chau et al., HuM291 (NUVION), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor, TRANSPLANT, 71(7), 2001, pp. 941-950
Authors:
Isern, J
Giovannelli, F
Sabau, L
Bravo, E
Gomez-Gomar, J
Hernanz, M
Garcia-Berro, E
La Padula, CD
Gutierrez, J
Jose, J
Garcia-Senz, D
Bausells, J
Cabestany, J
Madrenas, J
Angulo, M
Fernandez-Valbuena, M
Herrera, E
Reina, M
Talavera, A
Citation: J. Isern et al., SIXE: An x-ray experiment for the MINISAT platform, ASTRO SP SC, 276(1), 2001, pp. 39-48
Citation: Mm. Abu-hadid et al., Prevention of diabetes mellitus in the non-obese diabetic mouse strain with monoclonal antibodies against the CD45RB molecule, AUTOIMMUN, 32(1), 2000, pp. 73-76
Authors:
Carreno, BM
Bennett, F
Chau, TA
Ling, V
Luxenberg, D
Jussif, J
Baroja, ML
Madrenas, J
Citation: Bm. Carreno et al., CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression, J IMMUNOL, 165(3), 2000, pp. 1352-1356
Authors:
Xu, LL
Khandaker, MH
Barlic, J
Ran, LS
Borja, ML
Madrenas, J
Rahimpour, R
Chen, K
Mitchell, G
Tan, CM
DeVries, M
Feldman, RD
Kelvin, DJ
Citation: Ll. Xu et al., Identification of a novel mechanism for endotoxin-mediated down-modulationof CC chemokine receptor expression, EUR J IMMUN, 30(1), 2000, pp. 227-235
Authors:
Hess, DA
Sisson, ME
Suria, H
Wijsman, J
Puvanesasingham, R
Madrenas, J
Reider, MJ
Citation: Da. Hess et al., Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole, FASEB J, 13(13), 1999, pp. 1688-1698
Citation: J. Madrenas, Differential signalling by variant ligands of the T cell receptor and the kinetic model of T cell activation, LIFE SCI, 64(9), 1999, pp. 717-731
Citation: La. Chan et J. Madrenas, Phospho-LAT-independent activation of the Ras-mitogen-activated protein kinase pathway: A differential recruitment model of TCR partial agonist signaling, J IMMUNOL, 163(4), 1999, pp. 1853-1858
Citation: Ml. Baroja et al., Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation, J IMMUNOL, 162(4), 1999, pp. 2016-2023
Authors:
Gao, JX
Madrenas, J
Zeng, W
Cameron, MJ
Zhang, Z
Wang, JJ
Zhong, R
Grant, D
Citation: Jx. Gao et al., CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection, IMMUNOLOGY, 98(2), 1999, pp. 159-170
Authors:
Khandaker, MH
Mitchell, G
Xu, LL
Andrews, JD
Singh, R
Leung, H
Madrenas, J
Ferguson, SSG
Feldman, RD
Kelvin, DJ
Citation: Mh. Khandaker et al., Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression, BLOOD, 93(7), 1999, pp. 2173-2185